What does Beijing SL Pharmaceutical Co., Ltd. do?

Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 002038.SZ's market cap?

Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) has a market capitalization of approximately $6.45 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 002038.SZ pay a dividend?

Yes — Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) pays a dividend annually, with a trailing-twelve-month yield of 0.16%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

002038.SZ

Beijing SL Pharmaceutical Co., Ltd.

SHZ·Biotechnology · Healthcare

¥6.28¥0.09−1.41%

Market cap¥6.45B·Aug 26 7:04 AM UTC

Price Chart

¥6.28−¥0.09 (−1.41%)today

−33.54%CAGR −7.85%

Select date range

FromTo

Sep 9, 2004Aug 26, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)0.16%

Annual Dividend (FWD)¥0.01

Dividend Growth (5Y)−36.9%

Dividend Safety—

Payout Ratio120.6%

FCF Payout Ratio3.4%

Most Recent Dividend¥0.010

Ex-Dividend DateJul 22

Payment DateJul 22

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report DateJun 30

Reported vs Estimate¥0.07

Earnings Surprise—

FinancialsFinancials Tab

Revenue¥591.59M

Net Income−¥479.28M

Net Margin−81.0%

Operating Cash Flow¥384.67M

Capital Expenditures¥67.50M

Free Cash Flow¥317.17M

Return on Equity−9.4%

Return on Invested Capital−1.7%

Net Cash¥1.14B

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 002038.SZ and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 002038.SZ's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 002038.SZ and 80,000+ other tickers.

About Beijing SL Pharmaceutical Co., Ltd.

Operating both domestically within the People's Republic of China and across international markets, Beijing SL Pharmaceutical Co., Ltd. is a biopharmaceutical firm dedicated to the research, development, manufacturing, and commercialization of genetic engineering-based pharmaceuticals and associated medicinal products. Its extensive portfolio of finished pharmaceutical products encompasses a diverse range of medications, including but not limited to, temozolomide, arsenic trioxide, lenalidomide, docetaxel, paclitaxel, recombinant human granulocyte colony-stimulating factor (filgrastim)…

CEO: Mingbo Xu
Sector: Healthcare
Industry: Biotechnology
Exchange: SHZ
Employees: 901
Website: www.slpharm.com.cn

Peers

Peers Tab

000078.SZ

Shenzhen Neptunus Bioengineering Co., Ltd.

Cap

¥4.3B

000790.SZ

Chengdu Huasun Technology Group Inc., Ltd.

Cap

¥2.6B

000963.SZ

Huadong Medicine Co., Ltd

Cap

¥47.9B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 002038.SZ

What does Beijing SL Pharmaceutical Co., Ltd. do?: Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 002038.SZ's market cap?: Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) has a market capitalization of approximately $6.45 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 002038.SZ pay a dividend?: Yes — Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) pays a dividend annually, with a trailing-twelve-month yield of 0.16%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.